Kendle International

INC Research to close Old Lyme office

Wednesday, March 28, 2012 11:12 AM

INC Research, a CRO based in Raleigh, N.C., will be closing its Old Lyme office in Connecticut, laying off 66 employees in the process, according to the filing at the State of Connecticut Labor Department.

More... »


CRO top executives in a game of ‘musical chairs’

Monday, November 7, 2011 08:02 AM

Five months after INC Research’s acquisition of Kendle International closed, executives from the now-combined CRO are landing jobs with competitors.  

More... »


PPD names CEO, puts acquisition rumors in question

Monday, September 26, 2011 08:02 AM

PPD has named a new CEO, a move that strikes some in the industry as a little strange in the face of rumors that the publicly traded CRO is close to selling itself to a private equity firm.

More... »

PRA on the block, too?

Monday, August 8, 2011 08:02 AM

There was much hoopla made about PPD possibly being for sale after the Wall Street Journal published a story saying as much in mid-July. But what about its smaller competitor, PRA International?

More... »

INC Research completes acquisition of Kendle International

Wednesday, July 13, 2011 10:31 AM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO privately held by Avista Capital Partners and Ontario Teachers’ Pension Plan, has completed the acquisition of Kendle International in an all-cash transaction with a total equity value of approximately $232 million or $15.25 per share.

More... »

INC Research to acquire Kendle in all-cash deal to help compete for strategic deals with big pharma

Monday, May 9, 2011 09:38 AM

After months of rumors about Kendle International being on the block, CRO INC Research late last week announced it would buy the mid-tier publicly held CRO in an all-cash transaction. If the deal goes through, Kendle will be taken private.

More... »

INC Research to acquire Kendle International

Thursday, May 5, 2011 01:24 PM

INC Research, a therapeutically focused global CRO privately held by Avista Capital Partners and Ontario Teachers' Pension Plan, and CRO Kendle International, have jointly announced a definitive merger agreement. Raleigh, N.C.-based INC Research will acquire Kendle in an all-cash transaction with a total equity value of approximately $232 million.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs